Detection of botulinum toxins: Micromechanical and fluorescence-based sensors

Croatian Medical Journal

Volumn 46, Issue 4, 2005, Pages 491-497

  Parpura, Vladimir ^a   Chapman, Edwin R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CYAN FLUORESCENT PROTEIN; SNARE PROTEIN; SYNAPTOBREVIN; SYNAPTOBREVIN 2; SYNTAXIN 1A; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN;

BOTULISM; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; IMMUNOBLOTTING; IN VITRO STUDY; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVIEW; SENSOR; TOXIN ANALYSIS;

BOTULINUM TOXINS; CLOSTRIDIUM BOTULINUM; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; UNITED STATES;

EID: 24344504150     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Aureli P, Fenicia L, Pasolini B, Gianfranceschi M, McCroskey LM, Hatheway CL. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis. 1986;154:207-11.
2. Hall JD, McCroskey LM, Pincomb BJ, Hatheway CL. Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol. 1985;21:654-5.
3. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059-70.
4. Dong M, Richards DA, Goodnough MC, Tepp WH, Johnson EA, Chapman ER. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol. 2003;162:1293-303.
5. Nishiki T, Kamata Y, Nemoto Y, Omori A, Ito T, Takahashi M, et al. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem. 1994;269:10498-503.
6. Nishiki T, Tokuyama Y, Kamata Y, Nemoto Y, Yoshida A, Sato K, et al. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett. 1996; 378:253-7.
7. Nishiki T, Tokuyama Y, Kamata Y, Nemoto Y, Yoshida A, Sekiguchi M, et al. Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA. Neurosci Lett. 1996; 208:105-8.
8. Van Heyningen WE. The fixation of tetanus toxin, strychnine, serotonin and other substances by ganglioside. J Gen Microbiol. 1963;31:375-87.
9. Schiavo G, Matteoli M, Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev. 2000;80:717-66.
10. Humeau Y, Doussau F, Grant NJ, Poulain B. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie. 2000;82:427-46.
11. Berkow R, Fletcher AJ. The Merck manual of diagnosis and therapy. 16th ed. Rathway (NJ): Merck Research Laboratories; 1992.
12. Hatheway CL. Toxigenic clostridia. Clin Microbiol Rev. 1990;3:66-98.
13. Center for Disease Control and Prevention. Botulism. Atlanta, Georgia, 2003. Available from: http://www.bt.cdc gov/agent/botulism/index.asp. Accessed: May 10, 2005.
14. Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev. 1992;56:80-99.
15. Ellis DA, Tan AK. Cosmetic upper-facial rejuvenation with botulinum. J Otolaryngol. 1997;26:92-6.
16. Guerrissi J, Sarkissian P. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines. Ann Plast Surg. 1997;39:447-53.
17. Nowakowski A, Wang C, Powers DB, Amersdorfer P, Smith TJ, Montgomery VA, et al. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci U S A. 2002;99:11346-50.
18. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta BR, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992;359:832-5.
19. Schiavo G, Rossetto O, Benfenati F, Poulain B, Montecucco C. Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus. Ann N Y Acad Sci. 1994;710:65-75.
20. Sudhof TC, De Camilli P, Niemann H, Jahn R. Membrane fusion machinery: insights from synaptic proteins. Cell. 1993;75:1-4.
21. Keller JE, Nowakowski JL, Filbert MG, Adler M. Rapid microplate assay for monitoring botulinum neurotoxin B catalytic activity. J Appl Toxicol. 1999;19 Suppl 1:S13-7.
22. Peruski AH, Johnson LH 3rd, Peruski LF Jr. Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence assays. J Immunol Methods. 2002;263:35-41.
23. Baldwin MR, Bradshaw M, Johnson EA, Barbieri JT. The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability. Protein Expr Purif. 2004;37:187-95.
24. Liu W, Montana V, Chapman ER, Mohideen U, Parpura V. Botulinum toxin type B micromechanosensor. Proc Natl Acad Sci U S A. 2003;100:13621-5.
25. Dong M, Tepp WH, Johnson EA, Chapman ER. Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells. Proc Natl Acad Sci U S A. 2004;101:14701-6.
26. Cardullo RA, Parpura V. Fluorescence resonance energy transfer microscopy: theory and instrumentation. Methods Cell Biol. 2003;72:415-30.
27. Fernandez-Salas E, Steward LE, Ho H, Garay PE, Sun SW, Gilmore MA, et al. Plasma membrane localization signals in the light chain of botulinum neurotoxin. Proc Natl Acad Sci U S A. 2004;101:3208-13.